| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |